High serum concentrations of surfactant protein A in usual interstitial pneumonia compared with non-specific interstitial pneumonia

Thorax

Volumn 58, Issue 1, 2003, Pages 52-57

  Ishii, H ^a   Mukae, H ^a   Kadota, J ^b   Kaida, H ^a   Nagata, T ^a   Abe, K ^c   Matsukura, S ^c   Kohno, S ^a  

^a NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b OITA UNIVERSITY   (Japan)

^c UNIVERSITY OF MIYAZAKI   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; KL 6; SURFACTANT PROTEIN A; SURFACTANT PROTEIN D; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BRONCHIOLITIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; FEMALE; HUMAN; INTERSTITIAL PNEUMONIA; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SARCOIDOSIS;

ADULT; AGED; ANTIGENS; ANTIGENS, CD15; ANTIGENS, NEOPLASM; BIOLOGICAL MARKERS; BRONCHOALVEOLAR LAVAGE FLUID; CA-19-9 ANTIGEN; CELL COUNT; FEMALE; GLYCOPROTEINS; HUMANS; LUNG DISEASES, INTERSTITIAL; MALE; MIDDLE AGED; MUCINS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B;

EID: 0037260159     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.1.52     Document Type: Article

References (31)

1. Katzenstein AA, Fiorelli RF. Nonspecific interstitial pneumonia/fibrosis. Histologic features and clinical significance. Am J Surg Pathol 1994;18:136-47.
2. Travis WD, Matsui K, Moss J, et al. Idiopathic nonspecific interstitial pneumonia: Prognostic significance of cellular and fibrosing patterns: survival comparison with usual interstitial pneumonia and desquamative interstitial pneumonia. Am J Surg Pathol 2000;24:19-33.
3. Katzenstein AA, Myers JL. Nonspecific interstitial pneumonia and the other idiopathic interstitial pneumonias: classification and diagnostic criteria. Am J Surg Pathol 2000;24:1-3.
4. Daniil ZD, Gilchrist FC, Nicholson AG, et al. A histologic pattern of nonspecific interstitial pneumonia is associated with a better prognosis than usual interstitial pneumonia in patients with cryptogenic fibrosing alveolitis. Am J Respir Crit Care Med 1999;160:899-905.
5. Cottin V, Donsbeck AV, Revel D, et al. Nonspecific interstitial pneumonia: Individualization of a clinicopathologic entity in a series of 12 patients. Am J Respir Crit Care Med 1998;158:1286-93.
6. Nagai S, Kitaichi M, Itoh H, et al. Idiopathic nonspecific interstitial pneumonia/fibrosis: Comparison with idiopathic pulmonary fibrosis and BOOP. Eur Respir J 1998;12:1010-19.
7. Myers JL. NSIP, UIP, and the ABCs of idiopathic interstitial pneumonias. Eur Respir J 1998;12:1003-4.
8. Bjoraker JA, Ryu JH, Edwin MK, et al. Prognostic significance of histopathologic subsets in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1998;157:199-203.
9. Katzenstein AA, Myers JL. Idiopathic pulmonary fibrosis: Clinical relevance of pathologic classification. Am J Respir Crit Care Med 1998;157:1301-15.
10. Hunninghake GW, Zimmerman MB, Schwartz DA, et al. Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 2001;164:193-6.
11. Shijubo N, Honda Y, Itoh Y, et al. BAL surfactant protein A and Clara cell 10-kDa protein levels in healthy subjects. Lung 1998;176:257-65.
12. Takahashi H, Fujishima T, Koba H, et al. Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent. Am J Respir Crit Care Med 2000;162:1109-14.
13. Honda Y, Kuroki Y, Matsuura E, et al. Pulmonary surfactant protein D in sera and bronchoalveolar lavage fluids. Am J Respir Crit Care Med 1995;152:1860-6.
14. Kuroki Y, Takahashi H, Chiba H, et al. Surfactant proteins A and D: disease markers. Biochim Biophys Acta 1998;1408:334-45.
15. McCormack FX, King TE, Jr., Bucher BL, et al. Surfactant protein A predicts survival in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 1995;152:751-9.
16. Yokoyama A, Kohno N, Kondo K, et al. Comparative evaluation of sialylated carbohydrate antigens, KL-6, CA19-9 and SLX as serum markers for interstitial pneumonia. Respirology 1998;3:199-202.
17. Kannagi R, Fukushi Y, Tachikawa T, et al. Quantitative and qualitative characterization of human cancer-associated serum glycoprotein antigens expressing fucosyl or sialyl-fucosyl type 2 chain polylactosamine. Cancer Res 1986;46:2619-26.
18. Magnani JL, Steplewski Z, Koprowski H, et al. Identification of the gastrointestinal and pancreatic cancer-associated antigen detected by monoclonal antibody 19-9 in the sera of patients as a mucin. Cancer Res 1983;43:5489-92.
19. Kohno N, Akiyama M, Kyoizumi S, et al. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1985;18:203-16.
20. Sato H, Kamma H, Ogata T, et al. Clinical significance of serum levels of a carbohydrate antigen, sialyl SSEA-1, in patients with fibrosing lung disease. Am Rev Respir Dis 1991;144:1177-81.
21. Mukae H, Hirota M, Kohno S, et al. Elevation of tumor-associated carbohydrate antigens in patients with diffuse panbronchiolitis. Am Rev Respir Dis 1993;148:744-51.
22. Kohno N, Kyoizumi S, Awaya Y, et al. New serum indicator of interstitial pneumonitis activity: Sialylated carbohydrate antigen KL-6. Chest 1989;96:68-73.
23. Kobayashi J and Kitamura S. KL-6: A serum marker for interstitial pneumonia. Chest 1995;108:311-5.
24. Kohno N, Awaya Y, Oyama T, et al. KL-6, a mucin-like glycoprotein, in bronchoalveolar lavage fluid from patients with interstitial lung disease. Am Rev Respir Dis 1993;148:637-42.
25. Homma H, Yamanaka A, Tanimoto S, et al. Diffuse panbronchiolitis: a disease of the transitional zone of the lung. Chest 1983;83:63-9.
26. Mukae H, Kadota J, Kohno S, et al. Increase in activated CD8+ cells in bronchoalveolar lavage fluid in patients with diffuse panbronchiolitis. Am J Respir Crit Care Med 1995;152:613-8.
27. Kubo M, Ihn H, Yamane K, et al. Serum KL-6 in adult patients with polymyositis and dermatomyositis. Rheumatology 2000;39:632-6.
28. Nakajima H, Harigai M, Hara M, et al. KL-6 as a novel serum marker for interstitial pneumonia associated with collagen diseases. J Rheumatol 2000;27:1164-70.
29. Fukaya S, Oshima H, Kato K, et al. KL-6 as a novel serum marker for activities of interstitial pneumonia in connective tissue diseases. Rheumatol Int 2000;19:223-5.
30. Takahashi H, Kuroki Y, Tanaka H, et al. Serum levels of surfactant proteins A and D are useful biomarkers for interstitial lung disease in patients with progressive systemic sclerosis. Am J Respir Crit Care Med 2000;162:258-63.
31. Obayashi Y, Fujita J, Nishiyama T, et al. Role of carbohydrate antigens sialyl Lewis (a) CA19-9) in bronchoalveolar lavage in patients with pulmonary fibrosis. Respiration 2000;67:146-52.